LncRNA WWOX-AS1 sponges miR-20b-5p in hepatocellular carcinoma and represses its progression by upregulating WWOX. Issue 10 (2nd October 2020)
- Record Type:
- Journal Article
- Title:
- LncRNA WWOX-AS1 sponges miR-20b-5p in hepatocellular carcinoma and represses its progression by upregulating WWOX. Issue 10 (2nd October 2020)
- Main Title:
- LncRNA WWOX-AS1 sponges miR-20b-5p in hepatocellular carcinoma and represses its progression by upregulating WWOX
- Authors:
- Xu, Dafeng
Liu, Xiangmei
Wu, Jincai
Wang, Yu
Zhou, Kailun
Chen, Wenmei
Chen, Jiacheng
Chen, Cheng
Chen, Liang - Abstract:
- ABSTRACT: Increasing evidence has revealed that long noncoding RNAs (lncRNAs) emerge as pivotal regulators in diverse cancers, including hepatocellular carcinoma (HCC). This study was conducted to investigate the role of lncRNA WWOX antisense RNA 1 (WWOX-AS1) in HCC progression. Our present study illustrated that WWOX-AS1 was lowly expressed in HCC tissues and cell lines. High WWOX-AS1 expression was further confirmed to predict a favorable prognosis in HCC patients. Through functional assays, we observed that upregulated WWOX-AS1 was correlated with decreased cell proliferation, migration, epithelial to mesenchymal transition (EMT) process and increased cell apoptosis, suggesting that WWOX-AS1 exerted anti-carcinogenic role in the development of HCC. Moreover, WWOX, the nearby gene of WWOX-AS1, was found at a low level in HCC tissues and cell lines. Furthermore, there was a positive relationship between WWOX-AS1 and WWOX. Additionally, WWOX overexpression hampered cell proliferation, migration, EMT process and induced cell apoptosis in HCC. Mechanically, WWOX-AS1 was identified as a cytoplasmic RNA in HCC cells and sponged miR-20b-5p to regulate WWOX expression. Rescue assays further indicated that WWOX knockdown counteracted WWOX-AS1 overexpression-mediated suppressive function on HCC progression. Collectively, WWOX-AS1/miR-20b-5p/WWOX axis suppresses HCC tumorigenesis, hinting a potential molecular mechanism for the therapy of HCC patients.
- Is Part Of:
- Cancer biology & therapy. Volume 21:Issue 10(2020)
- Journal:
- Cancer biology & therapy
- Issue:
- Volume 21:Issue 10(2020)
- Issue Display:
- Volume 21, Issue 10 (2020)
- Year:
- 2020
- Volume:
- 21
- Issue:
- 10
- Issue Sort Value:
- 2020-0021-0010-0000
- Page Start:
- 927
- Page End:
- 936
- Publication Date:
- 2020-10-02
- Subjects:
- WWOX-AS1 -- miR-20b-5p -- WWOX -- HCC
616.99406 - Journal URLs:
- http://www.tandfonline.com/ ↗
- DOI:
- 10.1080/15384047.2020.1806689 ↗
- Languages:
- English
- ISSNs:
- 1538-4047
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3046.456700
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 22949.xml